The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study

BACKGROUND: Although effective, some oral pre-exposure prophylaxis (PrEP) users face barriers to adherence using daily pills, which could be reduced by long-acting formulations. Long-acting cabotegravir (CAB LA) is a potential new injectable formulation for human immunodeficiency virus (HIV) PrEP be...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jennifer A, Garnett, Geoffrey P, Hallett, Timothy B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514192/
https://www.ncbi.nlm.nih.gov/pubmed/32492704
http://dx.doi.org/10.1093/infdis/jiaa296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514192/
https://www.ncbi.nlm.nih.gov/pubmed/32492704
http://dx.doi.org/10.1093/infdis/jiaa296

Ejemplares similares